206 related articles for article (PubMed ID: 32393869)
1. Stromal reactivity differentially drives tumour cell evolution and prostate cancer progression.
Frankenstein Z; Basanta D; Franco OE; Gao Y; Javier RA; Strand DW; Lee M; Hayward SW; Ayala G; Anderson ARA
Nat Ecol Evol; 2020 Jun; 4(6):870-884. PubMed ID: 32393869
[TBL] [Abstract][Full Text] [Related]
2. Investigating prostate cancer tumour-stroma interactions: clinical and biological insights from an evolutionary game.
Basanta D; Scott JG; Fishman MN; Ayala G; Hayward SW; Anderson AR
Br J Cancer; 2012 Jan; 106(1):174-81. PubMed ID: 22134510
[TBL] [Abstract][Full Text] [Related]
3. Using high throughput microtissue culture to study the difference in prostate cancer cell behavior and drug response in 2D and 3D co-cultures.
Mosaad E; Chambers K; Futrega K; Clements J; Doran MR
BMC Cancer; 2018 May; 18(1):592. PubMed ID: 29793440
[TBL] [Abstract][Full Text] [Related]
4. Asporin is a stromally expressed marker associated with prostate cancer progression.
Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
[TBL] [Abstract][Full Text] [Related]
5. Bone-stromal cells up-regulate tumourigenic markers in a tumour-stromal 3D model of prostate cancer.
Windus LC; Glover TT; Avery VM
Mol Cancer; 2013 Sep; 12(1):112. PubMed ID: 24073816
[TBL] [Abstract][Full Text] [Related]
6. YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression.
Shen T; Li Y; Zhu S; Yu J; Zhang B; Chen X; Zhang Z; Ma Y; Niu Y; Shang Z
J Exp Clin Cancer Res; 2020 Feb; 39(1):36. PubMed ID: 32066485
[TBL] [Abstract][Full Text] [Related]
7. Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts.
Comito G; Pons Segura C; Taddei ML; Lanciotti M; Serni S; Morandi A; Chiarugi P; Giannoni E
Oncotarget; 2017 Jan; 8(1):118-132. PubMed ID: 27223431
[TBL] [Abstract][Full Text] [Related]
8. A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer.
Pértega-Gomes N; Vizcaíno JR; Attig J; Jurmeister S; Lopes C; Baltazar F
BMC Cancer; 2014 May; 14():352. PubMed ID: 24886074
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Nox4-dependent ROS signaling attenuates prostate fibroblast activation and abrogates stromal-mediated protumorigenic interactions.
Sampson N; Brunner E; Weber A; Puhr M; Schäfer G; Szyndralewiez C; Klocker H
Int J Cancer; 2018 Jul; 143(2):383-395. PubMed ID: 29441570
[TBL] [Abstract][Full Text] [Related]
10. Stromal-epithelial interactions in prostate cancer: Overexpression of PAGE4 in stromal cells inhibits the invasive ability of epithelial cells.
Fu S; Liu T; Lv C; Fu C; Zeng R; Kakehi Y; Kulkarni P; Getzenberg RH; Zeng Y
J Cell Biochem; 2020 Nov; 121(11):4406-4418. PubMed ID: 32003504
[TBL] [Abstract][Full Text] [Related]
11. Macrophage inhibitory cytokine-1 induced by a high-fat diet promotes prostate cancer progression by stimulating tumor-promoting cytokine production from tumor stromal cells.
Huang M; Narita S; Koizumi A; Nara T; Numakura K; Satoh S; Nanjo H; Habuchi T
Cancer Commun (Lond); 2021 May; 41(5):389-403. PubMed ID: 33773090
[TBL] [Abstract][Full Text] [Related]
12. Development of a predictive model for stromal content in prostate cancer samples to improve signature performance.
Boufaied N; Takhar M; Nash C; Erho N; Bismar TA; Davicioni E; Thomson AA
J Pathol; 2019 Dec; 249(4):411-424. PubMed ID: 31206668
[TBL] [Abstract][Full Text] [Related]
13. Progesterone receptor in the prostate: A potential suppressor for benign prostatic hyperplasia and prostate cancer.
Chen R; Yu Y; Dong X
J Steroid Biochem Mol Biol; 2017 Feb; 166():91-96. PubMed ID: 27125450
[TBL] [Abstract][Full Text] [Related]
14. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.
Fong EL; Wan X; Yang J; Morgado M; Mikos AG; Harrington DA; Navone NM; Farach-Carson MC
Biomaterials; 2016 Jan; 77():164-72. PubMed ID: 26599623
[TBL] [Abstract][Full Text] [Related]
15. Identification of a unique epigenetic sub-microenvironment in prostate cancer.
Rodriguez-Canales J; Hanson JC; Tangrea MA; Erickson HS; Albert PS; Wallis BS; Richardson AM; Pinto PA; Linehan WM; Gillespie JW; Merino MJ; Libutti SK; Woodson KG; Emmert-Buck MR; Chuaqui RF
J Pathol; 2007 Mar; 211(4):410-9. PubMed ID: 17278115
[TBL] [Abstract][Full Text] [Related]
16. Stromal hedgehog signaling maintains smooth muscle and hampers micro-invasive prostate cancer.
Yang Z; Peng YC; Gopalan A; Gao D; Chen Y; Joyner AL
Dis Model Mech; 2017 Jan; 10(1):39-52. PubMed ID: 27935821
[TBL] [Abstract][Full Text] [Related]
17. LIM domain only 2 over-expression in prostate stromal cells facilitates prostate cancer progression through paracrine of Interleukin-11.
Jiang CY; Yu JJ; Ruan Y; Wang XH; Zhao W; Wang XJ; Zhu YP; Gao Y; Hao KY; Chen L; Han BM; Xia SJ; Zhao FJ
Oncotarget; 2016 May; 7(18):26247-58. PubMed ID: 27028859
[TBL] [Abstract][Full Text] [Related]
18. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
19. The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1.
Li SM; Wu HL; Yu X; Tang K; Wang SG; Ye ZQ; Hu J
J Exp Clin Cancer Res; 2018 Sep; 37(1):219. PubMed ID: 30185212
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C
Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
